LCN2 and cholangiocarcinoma: We found that all cholangiocarcinoma specimens (24/24 cases) demonstrated the signaling for NGAL expression and intense expression of NGAL protein was noted in 75.0% (18/24 cases) of cholangiocarcinoma specimens [12].